Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.
Howard MengM Gabrielle PagePrabjit AjrawatAmol DeshpandeBana SammanMary DominicisKarim S LadhaJoseph FiorellinoAlexander HuangYuvaraj KotteeswaranAlex McClaren-BladesLakshmi P KotraHance A ClarkePublished in: Canadian journal of anaesthesia = Journal canadien d'anesthesie (2021)
Despite significant challenges to collecting long-term observational data on patients who attempted a trial of cannabis products, approximately one-third of patients in the cohort remained on medical cannabis for six months. In this cohort, pain intensity and pain-related interference scores were reduced and QoL and general health symptoms scores were improved compared with baseline.
Keyphrases
- chronic pain
- patient reported outcomes
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- peritoneal dialysis
- pain management
- clinical trial
- mental health
- physical activity
- spinal cord injury
- spinal cord
- climate change
- electronic health record
- data analysis
- drug induced
- human health